MeSH D003693 - delirium
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D019965:Neurocognitive disorders
0 Companies
0 Drugs
Success rate
D003221:Confusion
0 Companies
0 Drugs
Success rate
D003693:Â
Delirium
D000071257:Emergence delirium
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Propofol | Propofol |  | 2000-09-19 |  |  |
| Dr Reddys Laboratories | Propofol | Propofol |  | 2018-11-15 |  |  |
| Hospira | Propofol | Propofol |  | 2006-03-17 |  |  |
| Hikma Pharmaceuticals | Propofol | Propofol |  | 2005-04-19 |  |  |
| Fresenius Kabi | Propofol | Diprivan | 2024-12-01 | 1989-10-02 |  |  |
| Sagent Pharmaceuticals | Propofol | Propofol |  | 1999-01-04 |  |  |
| InnoPharma Licensing | Propofol | Propofol |  | 2020-09-16 |  |  |
| Avet Lifesciences | Propofol | Propofol |  | 2021-10-12 |  |  |
| Allergan | Propofol | Propofol |  | 2015-12-22 |  |  |
| Aspiro Pharma | Propofol | Propofol |  | 2024-06-20 |  |  |
1
2
>
Clinical Trials
Historical Success Rate
Phase 1
95%18/19
Phase 2
66%23/35
Phase 3
58%18/31
Approved: 1Overall Success rate: 36%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use